COMPANY PROFILE

Biomica

Explore full profile

Develops microbiome-based therapeutics to treat immune-mediated and infectious diseases

Rehovot, IsraelFounded 2017Biotech & Life Sciences

Valuation $50–100M Last recorded · 2022

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Biomica

Biomica operates in the biotechnology sector, focusing on advanced microbial and genomic profiling to facilitate precision medicine and therapeutic discovery. The company serves healthcare providers, pharmaceutical companies, and research institutions by offering high-resolution taxonomy analysis of microbial communities, profiling of patients' genomic information, and functional analysis of microbial genes, pathways, and metabolites. Biomica's proprietary PRISM platform integrates microbiome profiles with genomic and phenotypic host profiles to make clinically relevant predictions. The business model revolves around leveraging its computational solutions and virtual screening platforms to identify unique microbiome-based therapeutic entities, which are then developed through preclinical and clinical phases. Revenue is generated through partnerships, licensing agreements, and the commercialization of its therapeutic discoveries.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Rehovot, Israel
Employees: 5
Open positions: None listed
Dealroom signal: 57.7/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Precision Medicine, Synthetic Biology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
Other✓Other financing	Apr 2023	$10M	—	Evogene	↗
EARLY VC✓Equity / VC	Dec 2022	$10M	$40M	Shanghai Healthcare Capital	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Biomica website traffic

Latest recorded traffic for Biomica is 2K monthly website visits, up 9900% over the last three months. Biomica's team declined 50% over the past year.

Latest monthly visits2K 3-month web change+9900% 1-year team growth-50%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PBPersephone BiosciencesSynthetic biology company developing a platform to industrialize and scale the microbiome	San Diego, United States	Operational	22	$15M	$60M
DBDelve BioProviding Molecular Insights for the Precision Care of the Sickest Patients	Boston, United States	Operational
LOLogomixLarge-scale genome engineering platform for cell therapy	Tokyo, Japan	Operational
NONodus OncologyNext-generation precision medicines targeting DNA damage response	Macclesfield, United Kingdom	Operational
LBLeo Summit BiotechnologyCreating a characteristic research and development platform combining "engineering center + expert think tank + postdoctoral workstation" combining production, learning and research	China	Operational
BTBonum TherapeuticsFocused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines	Seattle, United States	Operational
CLClovernaRNA Targeted Drug Discovery Platform	Kurashiki, Japan	Operational
STSama TherapeuticsPrecision Neuropsychiatry AI/ML platform to accelerate psychedelic-inspired R&D	Cambridge, United States	Operational